Enteric Empty Capsules Sales Market to grow at a CAGR of 13.8% during 2024-2028
The Enteric Empty Capsules Sales Market is expected to grow at a CAGR of 13.8% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 62.9 million. The global enteric empty capsules market is experiencing significant growth due to the increasing prevalence of gastrointestinal (GI) diseases, such as ulcerative colitis, Crohn's disease, and other debilitating conditions. Pharmaceutical and biotechnology companies are prioritizing research and development efforts to discover and bring to market innovative therapeutic solutions for these conditions. This focus on novel, transformative treatments is anticipated to create lucrative opportunities for market expansion throughout the forecast period. Furthermore, the ongoing development of GI-targeted drugs by both regional and global vendors is poised to contribute substantially to the growth trajectory of the global enteric empty capsules market.
Get more information on Enteric Empty Capsules Sales Market by requesting a sample report
Technavio analysts predict that the Pharmaceutical subsegment will lead the End-user segment during 2024 and 2028 The Enteric Empty Capsules market represents a significant business opportunity for manufacturers and suppliers. These capsules, designed to protect their contents from stomach acid until they reach the intestines, are essential in various industries, including pharmaceuticals and nutraceuticals. Market growth is driven by increasing consumer health consciousness, a rising geriatric population, and advancements in technology. Companies that can deliver high-quality, reliable enteric capsules will be well-positioned to capitalize on this trend.
Here are the various ways based on which the market is segmented:
Key Companies and Market Insights
Some of the key companies in the Enteric Empty Capsules Sales Market include:
There are several factors that are causing the market to flourish rising incidence of gastrointestinal diseases
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
Enteric empty capsules have gained significant attention in the health and wellness industry due to their role in promoting gut health, mental well-being, and physical well-being. These capsules are designed to protect sensitive medications from stomach acid and release them in the intestine for optimal absorption. Health-conscious consumers are increasingly turning to whole grains, calcium, omega-3 fatty acids, minerals, vitamins, heart-healthy components, antioxidants, and fiber for improved health. Enteric empty capsules offer a convenient way to consume these nutrients, especially for those with inflammatory bowel diseases, ulcers, acid reflux, and other gastrointestinal disorders. Capsule manufacturing technologies have advanced to produce vegan and vegetarian alternatives made from plant-based materials. These capsules offer acid-resistant properties, ensuring the protection of acid-sensitive medications until they reach the intestine for intestinal release. Enteric empty capsules are also used for drug encapsulation, enhancing the bioavailability of active pharmaceutical ingredients and improving drug delivery systems. The use of these capsules is not limited to pharmaceuticals but also extends to nutraceuticals, providing a viable solution for those seeking optimal nutrient absorption and improved overall health. Healthcare awareness and the increasing prevalence of gastrointestinal disorders have fueled the demand for enteric empty capsules. The market for these capsules is expected to grow significantly in the coming years, driven by the need for effective oral drug delivery systems and the increasing popularity of plant-based alternatives.
The global pharmaceuticals market encompasses entities involved in the research and development (R&D) or manufacturing of various pharmaceutical offerings, including generic drugs, non-generic drugs, and veterinary drugs. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors propelling the expansion of the global pharmaceuticals market include the increasing elderly population. By 2050, approximately one-quarter of the US population is projected to be over 60 years old, while Europe is anticipated to reach a similar demographic ratio by 2030. This demographic shift is expected to fuel market growth as the elderly population tends to consume more healthcare products and services.
The Enteric Empty Capsules Sales Market is experiencing significant growth, fueled by the rising incidence of gastrointestinal diseases. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted